Elizabeth Hardaker

Elizabeth has more than 15 years’ experience in the pharmaceutical industry. Most recently, Elizabeth was a Senior Director at AstraZeneca leading a team supporting preclinical research in Oncology. Prior to that Elizabeth worked at Evotec in the Inflammation and immunology group and Novartis in the Respiratory group. Throughout her career Elizabeth has been the biology lead on a number of projects from across the drug discovery process ranging from target validation to those in clinical trials. Elizabeth has a PhD from the National Heart and Lung Institute, Imperial College and a Masters in Biochemistry from Bath University.